Companies: 10,795·Total market cap: $144.5T
Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTUNASDAQHealthcare● Active
$1.82
$-0.06(-3.19%)
Market Cap$43545051
P/E Ratio—
52W High$9.35
52W Low$1.58
Overview

Actuate Therapeutics Inc (ACTU) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001652935 · ACTU · NASDAQ · as of Jun 9, 2026

Filing snapshot

175
Total Filings
8-K
Latest Form
2026-05-22
Most Recent
2024
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001652935 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-26
Fiscal Year End
Mar 26, 2026
Accession No.
0001683168-26-002257
Primary Document
actuate_i10k-123125.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001652935 · Accession 0001683168-26-002257

Latest Key Filings

10-QQuarterly Report
FORM 10-Q FOR MAR 2026
2026-05-14
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2026-05-22Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
CURRENT REPORT
2026-05-22
View
S-8Employee Stock Plan Registration
INITIAL REGISTRATION STATEMENT
2026-05-14
View
10-QQuarterly Report
FORM 10-Q FOR MAR 2026
2026-05-14
View
8-KCurrent Report
FORM 8-K
2026-05-11
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-06
View
DEFA14AProxy Statement (Additional)
ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS
2026-05-06
View
8-KCurrent Report
CURRENT REPORT
2026-05-06
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-04-22
View
ARSARS
2025 ANNUAL REPORT
2026-04-09
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-06
View
DEF 14AProxy Statement
DEF 14A
2026-04-06
View
10-KAnnual Report
FORM 10-K FOR DEC 2025
2026-03-26
View
8-KCurrent Report
FORM 8-K
2026-01-12
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-12-17
View
8-KCurrent Report
CURRENT REPORT
2025-11-28
View
Showing 1–15 of 134 filingsForm 4 / 144 hidden· 175 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001652935  |  Exchange: NASDAQ · Healthcare

Actuate Therapeutics Inc (NASDAQ: ACTU) has submitted 175 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2024. As a Healthcare sector company with CIK 0001652935, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Actuate Therapeutics Inc's most comprehensive regulatory disclosure. The most recent Actuate Therapeutics Inc 10-K was filed on 2026-03-26 for fiscal year ending 2026. Historical ACTU 10-K annual reports are available from 2015 through 2026.

Investors researching Actuate Therapeutics Inc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ELTX SEC Filings →ALEC SEC Filings →NKTX SEC Filings →SPRO SEC Filings →MOLN SEC Filings →PEPG SEC Filings →VOR SEC Filings →MCRB SEC Filings →
→ ACTU Financials→ ACTU Earnings→ ACTU Insider Trades

Frequently Asked Questions

ACTU SEC Filings · 8 questions

Actuate Therapeutics Inc (ACTU) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 175 filings and access original documents at no cost. Actuate Therapeutics Inc's CIK is 0001652935.

ACTU SEC filingsActuate Therapeutics Inc SEC documentsfind ACTU 10-K